Longitudinal Study of the Human Intestinal Microbiome
Status:
Completed
Trial end date:
2011-01-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the human intestinal microbiota (microbes that live
inside and on human bodies) in healthy adults over a 6-month period and to study the effect
of an antibiotic on the intestinal microbiota. Participants will include up to 60 healthy
adult subjects, ages 18-45 years, from the Baltimore and University of Maryland communities.
Study procedures will include providing multiple stool samples throughout the study.
Participants will take a licensed antibiotic, Ciprofloxacin, for 3 days. Participants may be
involved in study related procedures for up to 7 months.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)